Moderna’s updated Covid-19 vaccine has been approved by the Canadian government.
Biotechnology company Moderna (MRNA.US) announced that after the United States, the Canadian government has approved its updated Covid-19 vaccine. The stock price rose 4.5% to $72.28 on Tuesday afternoon.
S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
Equities Mixed Intraday as Traders Weigh Macro Data, Await Fed Decision
Sector Update: Health Care Stocks Decline in Afternoon Trading
Sector Update: Health Care